胃癌发病趋年轻化 专家呼吁提升早筛预防意识

Core Viewpoint - Gastric cancer is a significant health threat in China, characterized by high incidence, mortality rates, and difficulty in treatment, with a notable trend of younger patients being diagnosed [1][2] Group 1: Disease Characteristics - Gastric cancer ranks fifth in incidence and third in mortality among malignant tumors in China, posing a severe risk to public health [1] - Approximately 65% of gastric cancer patients are diagnosed at an advanced stage, leading to low survival rates and high treatment challenges [1] Group 2: Risk Factors - The increase in gastric cancer cases among younger individuals is linked to poor lifestyle habits, dietary choices, Helicobacter pylori infection, and environmental factors [1] Group 3: HER2 and Treatment Advances - HER2 is a crucial driver gene in the development of gastric cancer, and effective targeting of this pathway is essential for improving patient prognosis [2] - The emergence of innovative treatments, such as Antibody-Drug Conjugates (ADCs), marks the transition to a precision-targeted treatment era for gastric cancer [2] - ADCs can specifically identify tumor cells and release chemotherapy drugs, addressing traditional treatment resistance and enhancing efficacy [2] Group 4: Early Detection and Prevention - There is a call for increased public awareness regarding early screening and prevention of gastric cancer, emphasizing that it is not "incurable" or "preventable" [2] - Regular endoscopic screenings and timely interventions for precancerous conditions can lead to early detection and management of gastric cancer [2] - The future outlook suggests that with ongoing advancements in targeted therapies, gastric cancer may evolve towards a chronic disease model similar to colorectal and breast cancers [2]